So, it is good to see the topic of greater consideration of women in trial design is being addressed. But it seems like regulators aren’t about to adopt plain language communication any time soon. And they’ve not made it straightforward to comment or contribute. To be fair, the same is true for the EMA (European Medicines Agency).
Consultation on the International Council for Harmonisation (ICH) E21 Guideline on the Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials
Consultation on the International Council for Harmonisation (ICH) E21 Guideline on the Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials
Closes 5th September.
https://www.gov.uk/government/consultations/consultation-on-the-international-council-for-harmonisation-ich-e21-guideline-on-the-inclusion-of-pregnant-and-breast-feeding-individuals-in-clinica